Established in September 1994, Nigale has carved out an impressive niche in the medical technology sector. By the close of 2024, it had amassed over 600 patents, a testament to its unwavering dedication to innovation. The company has independently developed a plethora of cutting-edge products that have substantially propelled the progress of the blood transfusion domain.

Nigale's product portfolio is extensive and diverse, spanning blood management devices, disposable kits, pharmaceuticals, and specialized software. This comprehensive range enables it to offer all-encompassing solutions tailored to the unique needs of plasma, blood centers, and hospitals. Among its standout innovations are the Blood Component Apheresis Separator and Blood Cell Separator, which have revolutionized blood treatment procedures.

Over the past three decades, Nigale has emerged as a trailblazer in China's blood transfusion industry. Its influence extends far beyond national borders, as its products have successfully penetrated over 40 countries and regions across the globe, bringing advanced medical technologies to patients worldwide.